Original: $489.00
-65%$489.00
$171.15The Story
B BRAUN 3103-11 DUPLEX DRUG DELIVERY SYSTEM 1g Cefazolin For Injection USP & Dextrose Injection USP, 50mL, 24/cs (147 cs/plt)
• Model: 3103-11
• Volume: 50mL
• Case of 24
• 147 Cases/ Pallet
A dual-chamber IV container now available in five cephalosporins that cover three generations of treatment. Conveniently activated at point of care, there is no need for freezing or special vials. Pre-filled drug and diluent chambers eliminate need for drug admixing and potential for associated medications errors, PVC-free, DEHP-free, latex-free.
This 1 g/50 mL dual‑chamber IV bag from B. Braun is designed to deliver a precise dose of the cephalosporin antibiotic cefazolin in a ready‑to‑activate format. The two‑chamber system (the “DUPLEX® Container”) separates the lyophilized drug product and the diluent (Dextrose Injection USP) until the moment of administration, thereby reducing the risk of procedural errors in reconstitution and simplifying workflow in busy pharmacy and clinical settings.
From a practical standpoint, the system offers significant convenience: no need for separate drug vials, manual drawing of diluent, or unsealing and mixing steps. Once the foil is removed and the seals activated, the diluent flows into the drug chamber, is mixed by simple agitation, and then the solution is ready for IV administration. This streamlined preparation helps reduce compounding time, limits exposure to airborne cephalosporins (which can be a concern in open‑vial workflows), and aligns with safety and efficiency initiatives in healthcare facilities. 3103-11
Clinically, after activation the solution is essentially iso‑osmotic (≈290 mOsmol/kg) and ready for IV administration. It provides a fixed 1 g dose of cefazolin in 50 mL of dextrose solution, making it straightforward for facilities to standardize dosing for appropriate indications (e.g., surgical prophylaxis or infection treatment in adults). The ready‑to‑use bag helps reduce preparation error, minimize waste, and improve turnaround from pharmacy to patient. Because the container is free from latex, PVC and DEHP, it carries additional safety advantages with respect to potential leachables and compatibility concerns for sensitive patient populations.
Description
B BRAUN 3103-11 DUPLEX DRUG DELIVERY SYSTEM 1g Cefazolin For Injection USP & Dextrose Injection USP, 50mL, 24/cs (147 cs/plt)
• Model: 3103-11
• Volume: 50mL
• Case of 24
• 147 Cases/ Pallet
A dual-chamber IV container now available in five cephalosporins that cover three generations of treatment. Conveniently activated at point of care, there is no need for freezing or special vials. Pre-filled drug and diluent chambers eliminate need for drug admixing and potential for associated medications errors, PVC-free, DEHP-free, latex-free.
This 1 g/50 mL dual‑chamber IV bag from B. Braun is designed to deliver a precise dose of the cephalosporin antibiotic cefazolin in a ready‑to‑activate format. The two‑chamber system (the “DUPLEX® Container”) separates the lyophilized drug product and the diluent (Dextrose Injection USP) until the moment of administration, thereby reducing the risk of procedural errors in reconstitution and simplifying workflow in busy pharmacy and clinical settings.
From a practical standpoint, the system offers significant convenience: no need for separate drug vials, manual drawing of diluent, or unsealing and mixing steps. Once the foil is removed and the seals activated, the diluent flows into the drug chamber, is mixed by simple agitation, and then the solution is ready for IV administration. This streamlined preparation helps reduce compounding time, limits exposure to airborne cephalosporins (which can be a concern in open‑vial workflows), and aligns with safety and efficiency initiatives in healthcare facilities. 3103-11
Clinically, after activation the solution is essentially iso‑osmotic (≈290 mOsmol/kg) and ready for IV administration. It provides a fixed 1 g dose of cefazolin in 50 mL of dextrose solution, making it straightforward for facilities to standardize dosing for appropriate indications (e.g., surgical prophylaxis or infection treatment in adults). The ready‑to‑use bag helps reduce preparation error, minimize waste, and improve turnaround from pharmacy to patient. Because the container is free from latex, PVC and DEHP, it carries additional safety advantages with respect to potential leachables and compatibility concerns for sensitive patient populations.
